Heartflow, Inc. (HTFL) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$16.68M*; Operating income -$17.90M; Depreciation and amortization $1.22M*.
- 2026-03-31: Basis Reported; EBITDA -$28.08M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$16.38M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$13.80M*; Operating income -$15.10M; Depreciation and amortization $1.30M*.
Complete source-backed ebitda history.
- Available history
- 2023-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$16.68M* | -$17.90M | $1.22M* | $64.08M | -26.03%* | $1.92M* | -$8.58M* | (m) | $26.26M | $44.83M | $22.00K |
|---|
| 2026-03-31 | Reported | -$28.08M | (m) | (m) | (m) | -53.40% | $1.89M | -$30.10M | (m) | $21.62M | $42.57M | $23.00K |
|---|
| 2025-12-31 | Reported | -$16.38M | (m) | (m) | (m) | -33.34% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$13.80M* | -$15.10M | $1.30M* | $46.28M | -29.81%* | $1.24M* | -$2.96M* | (m) | $17.30M | $33.22M | $30.00K |
|---|
| 2025-06-30 | Reported | -$12.32M* | -$13.71M | $1.40M* | $43.42M | -28.37%* | $790.00K* | -$27.30M* | (m) | $15.03M | $31.46M | $59.00K |
|---|
| 2025-03-31 | Reported | -$16.13M | (m) | (m) | (m) | -43.35% | $1.10M | -$13.17M | (m) | $13.92M | $31.52M | (m) |
|---|
| 2024-12-31 | Reported | -$14.47M | (m) | (m) | (m) | -41.36% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$13.54M* | -$14.93M | $1.39M* | $32.93M | -41.11%* | $1.02M* | -$10.27M* | (m) | $11.86M | $28.00M | $0.00 |
|---|
| 2024-06-30 | Reported | (m) | -$14.18M | (m) | $31.05M | (m) | (m) | (m) | (m) | $9.93M | $28.08M | $120.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$58.63M | (m) | (m) | (m) | -33.30% | $5.03M | -$54.02M | (m) | $64.92M | $134.34M | -$76.00K |
|---|
| 2024-12-31 | Reported | -$55.86M | (m) | (m) | (m) | -44.40% | $4.36M | -$69.00M | (m) | $43.52M | $112.15M | $53.00K |
|---|
| 2023-12-31 | Reported | -$68.17M | (m) | (m) | (m) | -78.20% | $6.11M | -$76.43M | (m) | $35.85M | $95.11M | $547.00K |
|---|